Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer

Acta Oto-Laryngologica

Volumn 132, Issue 10, 2012, Pages 1108-1114

  Furusaka, Tohru ^a,b   Asakawa, Takeshi ^a   Tanaka, Akane ^b   Matsuda, Hiroshi ^b   Ikeda, Minoru ^a  

^a NIHON UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Concurrent radiotherapy; Head and neck cancer; Nonresective treatment; Organ preservation; Pathological complete response

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; HYDROCORTISONE; PEPLEOMYCIN; SODIUM THIOSULFATE;

ADULT; AGED; ALOPECIA; ARTICLE; BIOPSY; CANCER CELL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CERVICAL LYMPH NODE; CLINICAL ARTICLE; DERMATITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FEMORAL ARTERY CATHETERIZATION; FOLLOW UP; HAIR LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LYMPH NODE METASTASIS; MALE; MEDICAL PROCEDURES; MOUTH SQUAMOUS CELL CARCINOMA; MUCOSA INFLAMMATION; NAUSEA; NECK DISSECTION; NEUTROPHIL COUNT; ORGAN PRESERVATION; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTE COUNT; TONGUE CANCER; TONGUE CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SALVAGE THERAPY; SURVIVAL ANALYSIS; TAXOIDS; TONGUE; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 84866710111     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2012.684702     Document Type: Article

References (13)

1. Holland JC, Rowland JH. 1989. Handbook of psycho-oncology: psychological care of the patient with cancer. New York: Oxford University Press. p 135-9.
2. Furusaka T, Matsuda H, Tanaka A, Ikeda M. 2010. Combination of superselective arterial injection chemotherapy and radiation therapy for tongue squamous cell carcinoma. IFN-HOS 2010, Seoul, Abstract Book. p 212.
3. Furusaka T. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer-for tongue cancer patients in comparison patients with other therapies]. Gan To Kagaku Ryoho 2006;33:1241-6; (in Japanese).
4. Furusaka T, Asakawa T, Sekine H, Matuzaki H, Ikeda M. Superselective intra-arterial chemotherapy and superselective intra-arterial chemotherapy with concomitant radiation therapy for squamous cell carcinoma of the tongue. Stomato-pharyngology 2010;23:243-7; (in Japanese).
5. Furusaka T, Kida A, Kukimoto N, Yokode Y, Horikawa Y, Makiyama K, et al. Combination chemotherapy with cyclo-phosphamide C, adriamycin (A), cis-platinumdiammine-dichloride (P) in head and neck malignant tumor-one day CAP regimen. Otologia 1985;31:471-7.
6. Furusaka T, Kida A, Aoyagi M, Makiyama K, Iida H, Miyakogawa M, et al. CAP therapy for advanced, recurrent and/or metastatic malignant tumors of the head and neck. Auris Nasus Larynx 1986;13(SUPPL. 1):S119-26.
7. Furusaka T, Kida A, Iida H, Yokode Y, Kikuchi K, Tomita H. Combination chemotherapy with CDDP and 5-FU in head and neck cancer. Auris Nasus Larynx 1986; 13(SUPPL. 1):S127-33.
8. Taguchi T, Furue H, Niitani H, Ishitani K, Kanamaru R. Ariyoshi, et al. Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug. Gan To Kagaku Ryoho 1984;21:1997-2005.
9. Pignon JP, Syz N, Posner M, Olivares R, Le Lann L, Yver A, et al. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck. Anticancer Drugs 2004;15:331-40.
10. Calais G, Pointreau Y, Alfonsi M, Sire C, Tuchais C, Tortochaux J, et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GOR-TEC 2000-01. ASCO Annual Meeting Proceedings 2006;24 (18S):5506.
11. Vermorken JB, Remenar E, Herpen VC, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357: 1695-704.
12. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-15.
13. Furusaka T, Kida A, Iizuka N, Kikuchi K, Tomita H. Combination chemotherapy with CDDP, 5-FU and PEP in head and neck malignant tumors. Auris Nasus Larynx 1986;13(SUPPL. 1):S135-42.